Win more clients.  Work faster.  Make up to 43% more placements.  True cloud software that never lets you down.

US Drugs Firm Set for Investment in Nottingham

A business which helps pharmaceutical firms’ new drug trials is investing in Nottingham after receiving grants nearing £1 million

A business which helps pharmaceutical firms’ new drug trials is making a major investment in Nottingham after receiving grants nearing £1 million.

The American-owned Parexel have been based in the city since it bought out ClinPhone, a business which designed technology which automatically gathered data from drug trials, for more that £90 million six years ago.

SplitFee.org Recruiters sharing jobs & splitting fees - IOR - The Recruiting Times

Attention Recruiters:
You will earn more if you join SplitFee.org – Don’t be the one missing out
3 Month Free Trial – Join now!

The company are now moving to new offices after consolidating its activities near the city centre, which is being part funded by two grants from the Nottingham Technology Grant Fund.

The grants total over £950,000 and will support the relocation of staff, currently around 600 people, and their plans to expand.

Parexel operate as a contract research operator in the global pharmaceutical industry and has 7 sites in the UK.

Jennifer Aquino, the vice-president, said “Parexel’s Nottingham operations play an important role in helping the company advance the worldwide success of the biopharmaceutical and medical device industries in preventing and curing disease.”

Nottingham City Council says that the grants from the Nottingham Technology Grant Fund will ensure the firm’s city operation continues to develop.

The leader of the Council, Jon Collins, added: “We are delighted with the announcement that Parexel will be expanding in the city. They are a company of international standing and also part of the life sciences industry, which is a strong point and a priority growth sector for the city. Our record of breakthroughs makes us the perfect location for Parexel.”

“There are some exciting developments ahead that will benefit the sector and the city as a whole.”

Comment on this story

Your email address will not be published. Required fields are marked *

*

Join the IOR to be part of creating excellence in recruiting standards & service